Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Golembo Myriam	2. Date of Event Requiring Statement (MM/DD/YYYY) 10/28/2019	3. Issuer Name and Ticker or Trading Symbol BiomX Inc. [PHGE]
(Last)        (First)        (Middle) C/O BIOMX LTD., 7 PINHAS SAPIR ST. FLOOR 2	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                          _____ 10% Owner ___X___ Officer (give title below)        _____ Other (specify below) Vice President of Development /
(Street) NESS ZIONA, L3 7414002       (City)              (State)              (Zip)	5. If Amendment, Date Original Filed(MM/DD/YYYY)	6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Options - Right to Buy	(1)	6/25/2027	Common Stock Options	38841	$1.69	D
Common Stock Options - Right to Buy	(2)	6/27/2028	Common Stock Options	7480	$1.97	D
Common Stock Options - Right to Buy	(3)	3/29/2029	Common Stock Options	29678	$2.03	D

Explanation of Responses:
(1)	25% of these options vested on June 25, 2018. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 16,993 shares of common stock were unvested.
(2)	25% of these options vested on June 27, 2019. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 5,145 shares of common stock were unvested.
(3)	25% of these options shall vest on March 29, 2020. Thereafter, the remaining options shall vest in 12 equal quarterly installments over three years. As of the reporting date, options to purchase 29,678 shares of common stock were unvested.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Golembo Myriam C/O BIOMX LTD. 7 PINHAS SAPIR ST. FLOOR 2 NESS ZIONA, L3 7414002			Vice President of Development

Signatures
/s/ Myriam Golembo		11/1/2019
**Signature of Reporting Person		Date